| |
| |
|
| Insider
Information: |
Sachdev Amit |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
71,325 |
|
|
Indirect Shares
|
7,447 |
|
|
| Direct
Value |
$24,511,741 |
|
|
|
Indirect Value
|
$3,299,393 |
|
|
| Total
Shares |
78,772 |
|
|
| Total
Value |
$27,811,135 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Vertex Pharmaceuticals Inc |
VRTX |
EVP Chief Patient & Ex... |
2024-05-15 |
55,325 |
2024-05-15 |
7,447 |
Premium* |
|
|
Celladon Corp |
CLDN |
|
2022-03-11 |
16,000 |
2020-03-12 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
193 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 5 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
• – – |
2018-05-15 |
4 |
AS |
$155.78 |
$12,930 |
D/D |
(83) |
46,662 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
• – – |
2018-06-29 |
4 |
AS |
$165.00 |
$686,615 |
D/D |
(4,096) |
46,662 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
• – – |
2018-06-29 |
4 |
OE |
$86.52 |
$364,148 |
D/D |
4,096 |
50,758 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
• – – |
2018-07-13 |
4 |
OE |
$96.87 |
$1,165,443 |
D/D |
12,031 |
58,693 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
• – – |
2018-07-13 |
4 |
AS |
$180.00 |
$2,165,580 |
D/D |
(12,031) |
46,662 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
• – – |
2018-07-16 |
4 |
OE |
$96.87 |
$166,520 |
D/D |
1,719 |
48,381 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
• – – |
2018-07-16 |
4 |
AS |
$180.14 |
$310,042 |
D/D |
(1,719) |
46,662 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
• – – |
2018-08-02 |
4 |
AS |
$175.06 |
$380,852 |
D/D |
(2,155) |
46,662 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
• – – |
2018-08-02 |
4 |
OE |
$91.05 |
$196,213 |
D/D |
2,155 |
48,817 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
• – – |
2018-08-03 |
4 |
OE |
$86.52 |
$168,022 |
D/D |
1,942 |
48,604 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
• – – |
2018-08-03 |
4 |
AS |
$174.50 |
$340,050 |
D/D |
(1,942) |
46,662 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
• – – |
2018-11-02 |
4 |
OE |
$91.05 |
$196,213 |
D/D |
2,155 |
48,817 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
• – – |
2018-11-02 |
4 |
AS |
$171.93 |
$372,505 |
D/D |
(2,155) |
46,662 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
• – – |
2018-11-05 |
4 |
OE |
$86.52 |
$167,935 |
D/D |
1,941 |
48,603 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
• – – |
2018-11-05 |
4 |
AS |
$172.70 |
$337,204 |
D/D |
(1,941) |
46,662 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
• – – |
2018-11-15 |
4 |
AS |
$163.75 |
$9,989 |
D/D |
(61) |
46,662 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
• – – |
2019-02-04 |
4 |
AS |
$186.52 |
$2,377,296 |
D/D |
(12,722) |
38,037 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
• – – |
2019-02-04 |
4 |
OE |
$86.52 |
$364,235 |
D/D |
4,097 |
48,817 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
• – – |
2019-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
37,223 |
75,260 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
• – – |
2019-02-11 |
4 |
AS |
$179.44 |
$6,319,216 |
D/D |
(35,095) |
40,165 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
• – – |
2019-05-15 |
4 |
AS |
$165.41 |
$10,090 |
D/D |
(61) |
33,416 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Policy, Access & Value |
• – – |
2014-10-28 |
4 |
OE |
$39.05 |
$468,600 |
D/D |
12,000 |
50,671 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Policy, Access & Value |
• – – |
2014-10-28 |
4 |
AS |
$115.00 |
$1,380,000 |
D/D |
(12,000) |
38,671 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Policy, Access & Value |
• – – |
2014-10-30 |
4 |
A |
$0.01 |
$400 |
D/D |
40,000 |
78,671 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Policy, Access & Value |
• – – |
2014-11-17 |
4 |
AS |
$111.97 |
$15,004 |
D/D |
(134) |
78,671 |
0 |
- |
|
193 Records found
|
|
Page 5 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
